SA to dispose of 2 million contaminated J&J Covid-19 vaccines biznews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biznews.com Daily Mail and Mail on Sunday newspapers.
South Africa to dispose of 2 million contaminated J&J vaccines
13 Jun 2021 - 19:24
Bloomberg
South Africa will dispose of 2 million Johnson & Johnson Covid-19 vaccines following a U.S. ruling that ingredients for the country’s doses may have been contaminated during production in a plant in Baltimore, according to President Cyril Ramaphosa.
The news marks a major setback in the country’s vaccine rollout just as a third wave of infections is gathering pace.
However, Aspen Pharmacare Holdings, Africa largest drugmaker, is set to begin the productionof new J&J vaccines by mid-week, Ramaphosa told reporters Sunday after he participated in the G-7 summit. He joined the meetings at the invitation of U.K. Prime Minister Boris Johnson.
Cloete said: “We can do a maximum of 70,000 vaccines next week, unless J&J starts coming back into the system.”
In the first week there were 18 sites and by Friday there will be 114. The plan is for 186, but the “supply problem will stymie this”, according to Cloete. “The supply constraints are not regarding the capacity at our sites to administer vaccines. We cannot do the intended 120,000 next week and that big supply constraint is a direct result of the non-delivery and non-release of the J&J doses.”
SA had ordered just over 30 million doses of the J&J vaccine, which only requires one jab, while Aspen Pharmacare Holdings, the country’s biggest drugmaker, has a contract to fill and package the vaccine at a local plant.
decisivemarketsinsightsMay 12, 2021
The
Thrombosis Drugs Market is expected to grow at a CAGR of 7.75% and is poised to reach US$XX Billion by 2027 as compared to US$XX Billion in 2020. The factors leading to this extraordinary growth is attributed to various market dynamics discussed in the report. Our experts have examined the market from a 360 degree perspective thereby producing a report which is definitely going to impact your business decisions.
In order to make a pre-order inquiry, kindly click on the link below:-
Thrombosis Drugs Market Overview
Several key pointers have been addressed through the market research industry analysis report. The pointers are like major demanding countries for the global market, factors that are fueling the growth of the market, the global industry size over the forecast period, the recent innovative trends in the global market and the restraining factors, and the market challenges in front of the global Thrombosis Drugs market.
Reuters
States in the African continent are calling for the establishment of full vaccine-manufacturing plants to prepare for future pandemics.
Most African countries are almost out of initial supplies and the continent accounts for just 2% of global administered shots.
The United States changed its stance to back the proposal this week, opening the door to negotiations between members of the World Trade Organization.
Rwanda, South Africa and Senegal are among countries calling for the establishment of full vaccine-manufacturing plants to prepare for future pandemics after Africa found itself at the back of the queue for Covid-19 shots.
While many developed nations are well advanced with their vaccination rollouts, most African countries are almost out of initial supplies and the continent accounts for just 2% of global administered shots, data from the Africa Centers for Disease Control and Prevention show.